Biblio Discovery — Demo Discovery Service

11 results for "Simone Birocchi"

Showing 1–11 · 0.19 seconds · RSS

  1. Journal Article

    Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review

    Simone Birocchi; Gian Marco Podda; Marco Manzoni et al.

    Platelets, Vol. 32 No. 2 · 2021 · English · DOAJ Scopus

    Previous meta-analyses reported discordant results on the efficacy and safety of thrombopoietin receptor agonists (TPO-RA) as second-line treatment in patients with immune thrombocytopenia (ITP). We conducted a meta-analysis of primary ITP treatment with the TPO-RA Romiplostim, Eltrombopag and…

  2. Journal Article Full text

    Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

    Marco Cattaneo; Elena Bertinato; Simone Birocchi et al.

    Thrombosis and Haemostasis · 2020 · English · OpenAlex Scopus

    Acutely ill medical patients are at heightened risk for venous thromboembolism, a term that combines deep vein thrombosis (DVT) and its more severe complication, pulmonary embolism.[ 1 ] [ 2 ] Although the incidence of venous thromboembolism in medical patients might have been overestimated in some…

  3. Journal Article

    Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review

    Gian Marco Podda; Elisa M. Fiorelli; Simone Birocchi et al.

    Platelets, Vol. 33 No. 1 · 2022 · English · DOAJ Scopus

    Immune thrombocytopenia (ITP) can be associated with lymphoproliferative diseases (LPD) or solid tumors. A systematic review of published literature was conducted to evaluate response to treatment of ITP secondary to malignancy. Primary outcome was overall response (complete response+response) to…

  4. Journal Article

    Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer

    Vincenzo Ronca; Matteo Barabino; Roberto Santambrogio et al.

    Hepatology Communications, Vol. 6 No. 2 · 2022 · English · DOAJ Scopus

    In patients with cirrhosis with severe thrombocytopenia (platelet count [PC] 100 × 109/L), intermediate (51‐100 × 109/L), and low (≤50 × 109/L). PC was also analyzed as a continuous covariate on multivariable analysis. The primary endpoint was major perioperative bleeding. The overall event rate of…

  5. Journal Article

    SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound

    Andrea Galassi; Francesca Casanova; Lidia Gazzola et al.

    Clinical Case Reports, Vol. 9 No. 2 · 2021 · English · DOAJ Dropped by Scopus 2021

    Abstract Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti‐inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID‐19.

  6. Journal Article

    Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease

    Bram M. M. Kremers; Simone Birocchi; Rene van Oerle et al.

    Frontiers in Cardiovascular Medicine, Vol. 6 · 2019 · English · DOAJ Scopus

    Background: Inflammation and hypercoagulability play a pivotal role in venous thromboembolism and atherothrombosis. Since venous thrombosis increases the risk of atherothrombotic events and vice versa, common mechanisms may be involved.Objectives: To elucidate the role of neutrophils and…

  7. Journal Article

    Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin

    Ingrid M. Bistervels; Roisin Bavalia; Jan Beyer‐Westendorf et al.

    Research and Practice in Thrombosis and Haemostasis, Vol. 6 No. 5 · 2022 · English · DOAJ Scopus

    Abstract Background Postthrombotic syndrome (PTS) is a long‐term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood but inadequate anticoagulant therapy with vitamin K antagonists is a known risk factor for the development of…

  8. Journal Article

    Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

    Roisin Bavalia; Ingrid M. Bistervels; Wim G. Boersma et al.

    Research and Practice in Thrombosis and Haemostasis, Vol. 5 No. 5 · 2021 · English · DOAJ Scopus

    Abstract Background Long‐term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has a key impact on late postthrombotic complications. We hypothesize that…